Neuhofen, Germany

Erich Schlick

This inventor holds 4 USPTO granted patents. Top assignees: Knoll Aktiengesellschaft, Basf Aktiengesellschaft. Active years: 1989-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erich Schlick. Retrieved from https://idiyas.com/inventor/erich-schlick-vs4zx1n9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 33(Granted Patents)


Location History:

  • Neuhofen, DE (1989 - 1991)
  • Otterstadt, DE (1992 - 1994)

Company Filing History:


Years Active: 1989-1994

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Erich Schlick

Introduction

Erich Schlick is a notable inventor based in Neuhofen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drugs for medical applications. With a total of 4 patents to his name, Schlick's work has had a meaningful impact on therapeutic practices.

Latest Patents

Among his latest patents, Schlick has focused on the use of TNF (Tumor Necrosis Factor) and LT (Lymphotoxin) for the preparation of drugs. These compounds are utilized for the prophylaxis and therapy of effusions in body cavities. His innovative approach in this area showcases his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Schlick has worked with prominent companies such as Knoll Aktiengesellschaft and BASF Aktiengesellschaft. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in pharmaceuticals.

Collaborations

Schlick has collaborated with notable individuals in his field, including Manfred Kaufmann and Ulrich Raeth. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Erich Schlick's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of effective medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…